Peptide therapy has started since 1920s with the advent of insulin application, and now it
has emerged as a new approach in treatment of diseases including cancer. Using anti-
cancer peptides (ACPs) is a promising way of cancer therapy as ACPs are continuing to be
approved and arrived at major pharmaceutical markets. Traditional cancer treatments face
different problems like intensive adverse effects to patient's body, cell resistance to
conventional chemical drugs and in some worse cases the occurrence of cell multidrug …